Make your money go further for just 25p per day

AIM IHT

Novacyt: on these numbers, the cheapest stock on the market

Novacyt Versalab image

AIM’s top performer from 2020 announces fabulous numbers, but that was last year, what of the future?


Novacyt (EURONEXT GROWTH: ALNOV; LON: NCYT ), the clinical diagnostics specialist and superstar performer from 2020, updated on trading for the year ending 31 December 2020. Here are the astonishing highlights from an incredible year:


Revenue +2400% to €311.6m (£277.0m) including revenue in the second half of the year of €239.2m (£213.7m).
EBITDA profitability above €210m (£187m), representing an EBITDA margin of more than 67%, after adding 124 people to the payroll.
Cash at 31 December 2020 was…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Novacyt SA

A refocused business delivers

30/09/2022 · Company Insights

Having survived a near death experience several years ago, a manufacturer of specialist industrial equipment covered…


Better than expected

17/06/2022 · Company Insights

Some welcome good news at last for shareholders in this provider of online competitions to win…


More Company Insights

Bonkers Bargains: another great update

18/07/2024 · Alumasc Group PLC

Chain cheers | Interest winner | Meaty first

17/07/2024 · Agronomics · Gateley · Renold · Team17

Big growth in human challenge trials

17/07/2024

Sign-up to our free email updates

SIGN UP